CardioComm Solutions, Inc.의 매출은 부문 또는 지역별로 어떻게 나뉘나요?
CardioComm Solutions, Inc. 주요 수익원은 Software Licensing이며, 최신 수익 발표에서 수익은 300,731입니다. 지역별로는 United States이 CardioComm Solutions, Inc.의 주요 시장이며, 수익은 349,810입니다.
CardioComm Solutions, Inc.은 수익성이 있나요?
no, 최신 재무제표에 따르면 CardioComm Solutions, Inc.의 순손실은 $0입니다.
CardioComm Solutions, Inc.에 부채가 있나요?
no, CardioComm Solutions, Inc.의 부채는 0입니다.
CardioComm Solutions, Inc.의 발행 주식은 몇 주인가요?
CardioComm Solutions, Inc.의 총 발행 주식은 0주입니다.
주요 통계
이전 종가
$0.0046
시가
$0.0073
일일 범위
$0.0046 - $0.0073
52주 범위
$0.003 - $0.011
거래량
5.0K
평균 거래량
0
배당수익률
--
EPS(TTM)
0.00
시가총액
$908.8K
CARDIOCOMM SOLUTIONS INC란 무엇인가요?
CardioComm Solutions, Inc. engages in the provision of management software solutions. The company is headquartered in North York, Ontario. The Company’s proprietary device connectivity and ECG management technologies are used in medical, consumer, clinical research and telemedicine solutions for recording, transmission, viewing, analyzing, reporting and storage of ECGs. The Global ECG Management Solutions (GEMS) and GlobalCardio (Cloud-based GEMS) products are licensed worldwide to hospitals, ECG commercial reading services and physicians. The company also holds Class II medical device clearances for the manufacture, marketing, and sales of personal ECG monitors direct to consumers. The products are marketed under the HeartCheck brand. The company developed compatibility of the HeartCheck device to its GEMS and GlobalCardio based software to enable use of the device for remote ECG/arrhythmia monitoring services.